Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
基本信息
- 批准号:7217960
- 负责人:
- 金额:$ 29.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsApoptosisBody WeightBody Weight decreasedCaloric RestrictionCaloriesCell ProliferationChemopreventive AgentChronicDevelopmentDietDietary ComponentDietary InterventionEffectiveness of InterventionsEnergy IntakeEpidemiologic StudiesEtiologyFatty acid glycerol estersFemaleGene ExpressionGoalsGrowth FactorHealthHumanIncidenceInsulin-Like Growth Factor IInsulin-Like-Growth Factor I ReceptorInterventionLeptinMammary NeoplasmsMammary glandMediatingModelingMusNutrientObesityOncogenesOutcomeOverweightPostmenopauseProtocols documentationRecording of previous eventsReportingRiskRodentRoleSerumSignal PathwaySignal TransductionSurrogate MarkersTissuesTransgenic MiceTransgenic OrganismsTreatment ProtocolsTumor BurdenWeightWomancancer riskfeedingfood restrictioninsightleptin receptormalignant breast neoplasmpreventprotective effectreceptorresponsetumor
项目摘要
DESCRIPTION (provided by applicant): Many attempts have been made to identify dietary components that prevent development of breast cancer and/or mammary tumors (MTs). Few studies have produced conclusive findings. However, chronic caloric restriction consistently lowers MT incidence and extends latency in rodents. We find that intermittent restriction/refeeding prevents MT development in transgenic MMTV-TGF-a mice to a greater degree than does chronic restriction, i.e., 3% vs 44% incidence (vs 77% for ad libitum-fed mice). Thus, the manner in which calories are restricted has a major impact on MT development. Hypotheses: 1- The protective effect of intermittent restriction/refeeding is mediated by decreased serum IGF-I and leptin and effects on signaling pathways and/or proliferation/apoptosis; 2-The protective effect of intermittent restriction/refeeding is dependent upon periods of moderately severe caloric restriction and is modified by caloric intake and/or nutrient composition during refeeding; 3- The protective effects of chronic restriction and intermittent restriction/refeeding are dependent upon tumor etiology. In Specific Aim 1 the effect of intermittent restriction/refeeding and chronic restriction on serum IGF-I and leptin in longitudinal and cross-sectional protocols will be assessed. In Specific Aim 2 the effect of intermittent restriction/refeeding and chronic restriction on apoptosis, proliferation, and gene expression of IGF-I and leptin and their receptors in mammary tissue and MTs will be determined. In Specific Aim 3 the effect of serum leptin levels on the protective response of intermittent restriction/refeeding regimen on MT development will be determined. Specific Aim 4 will determine if the protective effect of intermittent caloric restriction/refeeding is dependent upon the MT oncogene and/or background strain of the transgenic mouse. Our long-term objectives are to establish nutrition intervention strategies applicable to humans and/or to provide insights leading to the development of chemopreventive agents to mimic this protective effect.
描述(由申请人提供):已经进行了许多尝试来确定预防乳腺癌和/或乳腺肿瘤(MT)发展的饮食成分。很少有研究得出结论性的结论。然而,长期热量限制会持续降低啮齿动物的 MT 发生率并延长潜伏期。我们发现,间歇性限制/再喂养比长期限制更大程度地阻止转基因 MMTV-TGF-a 小鼠的 MT 发育,即,发生率分别为 3% 和 44%(随意喂养的小鼠为 77%)。因此,限制热量的方式对 MT 的发展有重大影响。假设: 1- 间歇性限制/重新喂养的保护作用是由血清 IGF-I 和瘦素减少以及对信号通路和/或增殖/凋亡的影响介导的; 2-间歇性限制/重新喂养的保护作用取决于中度严重热量限制的时期,并根据重新喂养期间的热量摄入和/或营养成分而改变; 3- 长期限制和间歇性限制/再喂养的保护作用取决于肿瘤病因。在具体目标 1 中,将评估纵向和横向方案中间歇性限制/再喂养和长期限制对血清 IGF-I 和瘦素的影响。在具体目标 2 中,将确定间歇性限制/再喂养和长期限制对乳腺组织和 MT 中 IGF-I 和瘦素及其受体的细胞凋亡、增殖和基因表达的影响。在具体目标 3 中,将确定血清瘦素水平对间歇性限制/再喂养方案对 MT 发育的保护反应的影响。具体目标 4 将确定间歇性热量限制/再喂养的保护作用是否取决于转基因小鼠的 MT 癌基因和/或背景品系。我们的长期目标是建立适用于人类的营养干预策略和/或提供有助于开发化学预防剂以模仿这种保护作用的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margot P Cleary其他文献
Margot P Cleary的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margot P Cleary', 18)}}的其他基金
Prevention of mammary tumors by metformin in comparison to calorie restriction
与热量限制相比,二甲双胍预防乳腺肿瘤
- 批准号:
8110818 - 财政年份:2011
- 资助金额:
$ 29.16万 - 项目类别:
Prevention of mammary tumors by metformin in comparison to calorie restriction
与热量限制相比,二甲双胍预防乳腺肿瘤
- 批准号:
8706080 - 财政年份:2011
- 资助金额:
$ 29.16万 - 项目类别:
Prevention of mammary tumors by metformin in comparison to calorie restriction
与热量限制相比,二甲双胍预防乳腺肿瘤
- 批准号:
8509624 - 财政年份:2011
- 资助金额:
$ 29.16万 - 项目类别:
Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
- 批准号:
7046000 - 财政年份:2004
- 资助金额:
$ 29.16万 - 项目类别:
Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
- 批准号:
6777829 - 财政年份:2004
- 资助金额:
$ 29.16万 - 项目类别:
Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
- 批准号:
6878568 - 财政年份:2004
- 资助金额:
$ 29.16万 - 项目类别:
Intermittent food restriction prevents mammary tumors
间歇性食物限制可预防乳腺肿瘤
- 批准号:
7368099 - 财政年份:2004
- 资助金额:
$ 29.16万 - 项目类别:
"FA" GENE, ADIPOCYTE LIPOGENESIS AND DIETARY FATTY ACIDS
“FA”基因、脂肪细胞脂肪生成和膳食脂肪酸
- 批准号:
3326406 - 财政年份:1989
- 资助金额:
$ 29.16万 - 项目类别:
"FA" GENE, ADIPOCYTE LIPOGENESIS AND DIETARY FATTY ACIDS
“FA”基因、脂肪细胞脂肪生成和膳食脂肪酸
- 批准号:
3326404 - 财政年份:1989
- 资助金额:
$ 29.16万 - 项目类别:
"FA" GENE, ADIPOCYTE LIPOGENESIS AND DIETARY FATTY ACIDS
“FA”基因、脂肪细胞脂肪生成和膳食脂肪酸
- 批准号:
3326405 - 财政年份:1989
- 资助金额:
$ 29.16万 - 项目类别:
相似国自然基金
STAB1调控Fas/FasL介导牦牛胎盘滋养层细胞凋亡及胎盘炎症性流产的作用与机制研究
- 批准号:32360836
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
萱草花细胞程序性凋亡生物钟调控机制研究
- 批准号:32371943
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于VEGFR2/Ca2+信号通路研究可视化针刀“调筋治骨”减轻颈椎病颈肌细胞凋亡的分子机制
- 批准号:82360940
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
STING/ALG-2复合物的结构及其在STING激活诱导的T细胞凋亡中的功能
- 批准号:32371265
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
SIRT2/Annexin A2/autophagy通路形成的分子机制及其在HCC细胞失巢凋亡抵抗中的作用研究
- 批准号:32300626
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Base Title: PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint BiomarkersTask Order Title: Colorectal Cancer (CRC) Prevention by TPST-1495 in PIRC rat mod
基本标题:预防临床前药物开发计划:临床前功效和中间终点生物标志物任务顺序标题:TPST-1495 在 PIRC 大鼠模型中预防结直肠癌 (CRC)
- 批准号:
10927554 - 财政年份:2023
- 资助金额:
$ 29.16万 - 项目类别:
Regulation of OXPHOS Assembly in Skeletal Muscles
骨骼肌中 OXPHOS 组装的调节
- 批准号:
10660712 - 财政年份:2023
- 资助金额:
$ 29.16万 - 项目类别:
The role of LPCAT3 in pathogenesis of diabetic cardiomyopathy
LPCAT3在糖尿病心肌病发病机制中的作用
- 批准号:
10867671 - 财政年份:2023
- 资助金额:
$ 29.16万 - 项目类别:
Rational design of anti-cancer therapeutics harnessing the synthetic lethality of methionine metabolism and arginine methyltransferases
利用蛋氨酸代谢和精氨酸甲基转移酶的合成杀伤力合理设计抗癌疗法
- 批准号:
10664872 - 财政年份:2022
- 资助金额:
$ 29.16万 - 项目类别:
Rational design of anti-cancer therapeutics harnessing the synthetic lethality of methionine metabolism and arginine methyltransferases
利用蛋氨酸代谢和精氨酸甲基转移酶的合成杀伤力合理设计抗癌疗法
- 批准号:
10536888 - 财政年份:2022
- 资助金额:
$ 29.16万 - 项目类别: